Supportive Care in Cancer

, Volume 20, Issue 11, pp 2697–2704 | Cite as

Functional status and health-related quality of life among allogeneic transplant patients at hospital discharge: a comparison of sociodemographic, disease, and treatment characteristics

  • Marcia Grant
  • Liz Cooke
  • Anna Cathy Williams
  • Smita Bhatia
  • Leslie Popplewell
  • Gwen Uman
  • Stephen Forman
Original Article

Abstract

Purpose

The purpose of this paper is to report the findings of a study of hematopoietic cell transplant patients, describing the needs of allogeneic transplant patients at the time of discharge in regard to their functional status, quality of life (QOL), and caregiver information and comparing these needs across a number of sociodemographic, disease, and treatment characteristics. The findings of this study are part of a larger mixed-methods study, representing one data time point of the larger study.

Methods

This paper will discuss the baseline data collected at the time of discharge for 282 allogeneic transplant patients, which include sociodemographic data combined with disease, treatment, functional status, and QOL data to present a comprehensive portrait of the transplant patient at discharge.

Results

Mean age was 48 years, males represented 52%, and 22% of the patients were Hispanic. The majority of the patients had acute leukemia (55%), were diagnosed within the last 3 years, and had matched unrelated (52%) transplants. The time from transplant to discharge averaged 30 days. Mean scores for QOL (scale = 1–10, with 10 = best QOL) included a low score of 5.7 for both psychological and social well-being, 6.3 for overall QOL, and 7.1 for both physical and spiritual well-being. Males had significantly higher QOL than females, as did non-Hispanics. Patients with Hodgkin’s disease had significantly lower overall QOL scores.

Conclusions

Our results highlight the physical, psychological, social, and spiritual challenges which present for patients and their caregivers at the time of hospital discharge following allogeneic transplant.

Keywords

Allogeneic transplant Discharge status Quality of life 

References

  1. 1.
    The Medical College of Wisconsin IatNMDP (2011) Accessed April 19, 2011Google Scholar
  2. 2.
    Appelbaum FR (2007) Hematopoietic-cell transplantation at 50. N Engl J Med 357(15):1472–1475. doi:10.1056/NEJMp078166 PubMedCrossRefGoogle Scholar
  3. 3.
    Gemmill R, Cooke L, Williams AC, Grant M (2011) Informal caregivers of hematopoietic cell transplant patients: a review and recommendations for interventions and research. Cancer Nurs 34:E13–E21. doi:10.1097/NCC.0b013e31820a592d PubMedCrossRefGoogle Scholar
  4. 4.
    Grulke N, Bailer H, Kachele H, Bunjes D (2005) Psychological distress of patients undergoing intensified conditioning with radioimmunotherapy prior to allogeneic stem cell transplantation. Bone Marrow Transpl 35(11):1107–1111CrossRefGoogle Scholar
  5. 5.
    Langer SL, Yi JC, Storer BE, Syrjala KL (2010) Marital adjustment, satisfaction and dissolution among hematopoietic stem cell transplant patients and spouses: a prospective, five-year longitudinal investigation. Psychooncology 19(2):190–200. doi:10.1002/pon.1542 PubMedCrossRefGoogle Scholar
  6. 6.
    Wilson ME, Eilers J, Heermann JA, Million R (2009) The experience of spouses as informal caregivers for recipients of hematopoietic stem cell transplants. Cancer Nurs 32(3):E15–E23. doi:10.1097/NCC.0b013e31819962e0 PubMedCrossRefGoogle Scholar
  7. 7.
    Andrykowski M, McQuellon R (2004) Psychosocial issues in hematopoietic cell transplantation. In: Blume KB, SJF, Appelbaum FR (eds) Thomas’ hematopoietic cell transplantation, 3rd edn. Blackwell Science LTD, Malden, Massachusetts, pp 497–506Google Scholar
  8. 8.
    Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, Bredeson CN, Carabasi MH, Gupta V, Hale GA, Khoury HJ, Juckett MB, Litzow MR, Martino R, McCarthy PL, Smith FO, Rizzo JD, Pasquini MC (2011) Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? J Clin Oncol 29(7):805–813. doi:10.1200/JCO.2010.32.5001 PubMedCrossRefGoogle Scholar
  9. 9.
    Pasquini MC, Wang Z (2009) Current use and outcome of hematopoietic stem cell transplantation: Part II- CIBMTR Summary Slides. CIBMTR Newsl 15(2):7–11Google Scholar
  10. 10.
    Grant M, Cooke L, Bhatia S, Forman S (2005) Discharge and unscheduled readmissions of adult patients undergoing hematopoietic stem cell transplantation: implications for developing nursing interventions. Oncol Nurs Forum 32(1):E1–E8. doi:10.1188/04.ONF.E1-E8 PubMedCrossRefGoogle Scholar
  11. 11.
    Hacker ED, Ferrans CE (2003) Quality of life immediately after peripheral blood stem cell transplantation. Cancer Nurs 26(4):312–322PubMedCrossRefGoogle Scholar
  12. 12.
    Grant M, Primary investigator (2005) RO1 CA 107446: a standardized nursing intervention protocol for HCT patients. National Cancer Institute, City of Hope Medical CenterGoogle Scholar
  13. 13.
    Grant M, Ferrell B, Schmidt GM, Fonbuena P, Niland JC, Forman SJ (1992) Measurement of quality of life in bone marrow transplantation survivors. Qual Life Res 1(6):375–384PubMedCrossRefGoogle Scholar
  14. 14.
    Saleh US, Brockopp DY (2001) Quality of life one year following bone marrow transplantation: psychometric evaluation of the quality of life in bone marrow transplant survivors tool. Oncol Nurs Forum 28(9):1457–1464PubMedGoogle Scholar
  15. 15.
    Wong FL, Francisco L, Togawa K, Bosworth A, Gonzales M, Hanby C, Sabado M, Grant M, Forman SJ, Bhatia S (2010) Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns. Blood 115(12):2508–2519. doi:10.1182/blood-2009-06-225631 PubMedCrossRefGoogle Scholar
  16. 16.
    Grant M (1999) Assessment of quality of life following hematopoietic cell transplantation. In: Forman SJ, Blum KG, Thomas ED (eds) Hematopoietic cell transplantation, 2nd edn. Blackwell Science, Inc., pp 407–413Google Scholar
  17. 17.
    King CR, Ferrell BR, Grant M, Sakurai C (1995) Nurses’ perceptions of the meaning of quality of life for bone marrow transplant survivors. Cancer Nurs 18(2):118–129PubMedCrossRefGoogle Scholar
  18. 18.
    Lynch JC, Morris ME, Bociek G, Bierman PJ, Vose JM, Armitage JO (2003) Quality of life of non-Hodgkin’s lymphoma survivors. Poster session presented at the annual conference of the International Society for Quality of Life Research. Prague, Czech RepublicGoogle Scholar
  19. 19.
    Byar KL, Eilers JE, Nuss SL (2005) Quality of life 5 or more years post-autologous hematopoietic stem cell transplant. Cancer Nurs 28(2):148–157PubMedCrossRefGoogle Scholar
  20. 20.
    Whedon M, Stearns D, Mills LE (1997) Quality of life of long-term cancer survivors. Oncol (Williston Park) 11(4):565–571Google Scholar
  21. 21.
    Morris AS, Lynch JC, Bociek G, Tarantolo S, Bierman PJ, Vose JM, Armitage JO (2003) Preliminary quality of life findings of patients undergoing hematopoietic stem cell transplant untilizing the City of Hope National Medical Center and Functional Assessment of Cancer Therapy Instruments. Clin Ther Supl D:D21–D22Google Scholar
  22. 22.
    McHorney CA, Ware JE Jr, Raczek AE (1993) The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31(3):247–263PubMedCrossRefGoogle Scholar
  23. 23.
    Bevans MF, Mitchell SA, Marden S (2008) The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). Support Care Cancer 16(11):1243–1254. doi:10.1007/s00520-008-0420-6 PubMedCrossRefGoogle Scholar
  24. 24.
    Lee SJ, Loberiza FR, Antin JH, Kirkpatrick T, Prokop L, Alyea EP, Cutler C, Ho VT, Richardson PG, Schlossman RL, Fisher DC, Logan B, Soiffer RJ (2005) Routine screening for psychosocial distress following hematopoietic stem cell transplantation. Bone Marrow Transpl 35(1):77–83. doi:10.1038/sj.bmt.1704709 CrossRefGoogle Scholar
  25. 25.
    Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME, Martin PJ (2004) Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 291(19):2335–2343. doi:10.1001/jama.291.19.2335 PubMedCrossRefGoogle Scholar
  26. 26.
    Flowers ME, Sullivan KM (2004) Management of patients undergoing marrow or blood stem cell transplantation. In: Atkinson K, RC, Ritz J, Fibbe W, Ljungman P, Brenner M (eds) Clinical bone marrow and blood stem cell transplantation. Cambridge University Press, Cambridge, UK, pp 313–336Google Scholar
  27. 27.
    Schmitz N (2004) Peripheral Blood Hematopoietic Cells for Allogeneic Transplantation. In: Blume KG, Fredrick SJF, Appelbaum R (eds) Thomas’ hematopoietic cell transplantation, 3rd edn. Blackwell Science Ltd, Malden, MassachusettesGoogle Scholar
  28. 28.
    Pavletic ZS, Bishop MR, Tarantolo SR, Martin-Algarra S, Bierman PJ, Vose JM, Reed EC, Gross TG, Kollath J, Nasrati K, Jackson JD, Armitage JO, Kessinger A (1997) Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. J Clin Oncol 15(4):1608–1616PubMedGoogle Scholar
  29. 29.
    Danaher EH, Ferrans C, Verlen E, Ravandi F, van Besien K, Gelms J, Dieterle N (2006) Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncol Nurs Forum 33(3):614–624. doi:10.1188/06.ONF.614-624 PubMedCrossRefGoogle Scholar
  30. 30.
    Gielissen MF, Schattenberg AV, Verhagen CA, Rinkes MJ, Bremmers ME, Bleijenberg G (2007) Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transpl 39(10):595–603. doi:10.1038/sj.bmt.1705624 CrossRefGoogle Scholar
  31. 31.
    Peniket AJ, Ruiz de Elvira MC, Taghipour G, Cordonnier C, Gluckman E, de Witte T, Santini G, Blaise D, Greinix H, Ferrant A, Cornelissen J, Schmitz N, Goldstone AH (2003) An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transpl 31(8):667–678. doi:10.1038/sj.bmt.1703891 CrossRefGoogle Scholar
  32. 32.
    Andorsky DJ, Loberiza FR, Lee SJ (2006) Pre-transplantation physical and mental functioning is strongly associated with self-reported recovery from stem cell transplantation. Bone Marrow Transpl 37(9):889–895. doi:10.1038/sj.bmt.1705347 CrossRefGoogle Scholar
  33. 33.
    van den Brink MR, Porter DL, Giralt S, Lu SX, Jenq RR, Hanash A, Bishop MR (2010) Relapse after allogeneic hematopoietic cell therapy. Biol Blood Marrow Transpl 16(1 Suppl):S138–S145. doi:10.1016/j.bbmt.2009.10.023 CrossRefGoogle Scholar
  34. 34.
    Sherman AC, Simonton S, Latif U, Spohn R, Tricot G (2004) Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation. Bone Marrow Transpl 33(9):955–962. doi:10.1038/sj.bmt.1704465 CrossRefGoogle Scholar
  35. 35.
    Morris ME, Grant M, Lynch JC (2007) Patient-reported family distress among long-term cancer survivors. Cancer Nurs 30(1):1–8PubMedCrossRefGoogle Scholar
  36. 36.
    Northouse LL, Katapodi MC, Song L, Zhang L, Mood DW (2010) Interventions with family caregivers of cancer patients: meta-analysis of randomized trials. CA Cancer J Clin 60(5):317–339. doi:10.3322/caac.20081 PubMedGoogle Scholar
  37. 37.
    Eldredge DH, Nail LM, Maziarz RT, Hansen LK, Ewing D, Archbold PG (2006) Explaining family caregiver role strain following autologous blood and marrow transplantation. J Psychosoc Oncol 24(3):53–74PubMedCrossRefGoogle Scholar
  38. 38.
    Cooke L, Chung C, Grant M (2011) Psychosocial care for adolescent and young adult hematopoietic cell transplant patients. J Psychosoc Oncol 29(4):394–414PubMedGoogle Scholar
  39. 39.
    Allen J (2008) A third of young adults uninsured in 2008: U.S. report. WashingtonGoogle Scholar
  40. 40.
    Thompson K, Palmer S, Dyson G (2009) Adolescents & young adults: issues in transition from active therapy into follow-up care. Eur J Oncol Nurs 13(3):207–212PubMedCrossRefGoogle Scholar
  41. 41.
    Prieto JM, Atala J, Blanch J, Carreras E, Rovira M, Cirera E, Gasto C (2004) Psychometric study of quality of life instruments used during hospitalization for stem cell transplantation. J Psychosom Res 57(2):201–211. doi:10.1016/j.jpsychores.2003.10.015 PubMedCrossRefGoogle Scholar
  42. 42.
    Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T (2001) Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transpl 28(5):503–509. doi:10.1038/sj.bmt.1703158 CrossRefGoogle Scholar
  43. 43.
    Cooke L, Gemmill R, Kravits K, Grant M (2009) Psychological issues of stem cell transplant. Semin Oncol Nurs 25(2):139–150. doi:10.1016/j.soncn.2009.03.008 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Marcia Grant
    • 1
  • Liz Cooke
    • 1
  • Anna Cathy Williams
    • 1
  • Smita Bhatia
    • 2
  • Leslie Popplewell
    • 3
  • Gwen Uman
    • 4
  • Stephen Forman
    • 3
  1. 1.Division of Nursing Research and EducationCity of HopeDuarteUSA
  2. 2.Division of Outcomes ResearchCity of HopeDuarteUSA
  3. 3.Division of HematologyCity of HopeDuarteUSA
  4. 4.Vital Research LLCLos AngelesUSA

Personalised recommendations